ATE420103T1 - Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen - Google Patents
Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionenInfo
- Publication number
- ATE420103T1 ATE420103T1 AT01972382T AT01972382T ATE420103T1 AT E420103 T1 ATE420103 T1 AT E420103T1 AT 01972382 T AT01972382 T AT 01972382T AT 01972382 T AT01972382 T AT 01972382T AT E420103 T1 ATE420103 T1 AT E420103T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv
- inhibitors
- treating
- infections caused
- replication
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
- 208000031886 HIV Infections Diseases 0.000 abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/648,557 US7790171B1 (en) | 2000-08-25 | 2000-08-25 | Antiviral peptides obtained from the tryptophan-rich hydrophobic cluster of the HIV-1 reverse transcriptase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420103T1 true ATE420103T1 (de) | 2009-01-15 |
Family
ID=24601279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01972382T ATE420103T1 (de) | 2000-08-25 | 2001-08-21 | Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7790171B1 (de) |
| EP (1) | EP1311538B1 (de) |
| AT (1) | ATE420103T1 (de) |
| AU (1) | AU2001292153A1 (de) |
| DE (1) | DE60137340D1 (de) |
| WO (1) | WO2002015661A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1305333A4 (de) * | 2000-07-31 | 2006-04-12 | Active Motif | Peptid-vermittelte lieferung von molekülen in zellen |
| AU2003233310A1 (en) * | 2002-05-08 | 2003-11-11 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Agent and method for transporting biologically active molecules in cells |
| EP2174948A1 (de) * | 2008-09-26 | 2010-04-14 | Centre National De La Recherche Scientifique | Antivirale Polypeptide |
| JP2012146377A (ja) * | 2011-01-14 | 2012-08-02 | Elpida Memory Inc | 半導体装置 |
| CN120289580B (zh) * | 2025-04-10 | 2025-09-12 | 甘肃中肽生物科技有限公司 | 牛骨髓蛋白肽的制备方法及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464933A (en) * | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
| EP1225907A4 (de) | 1999-10-05 | 2005-06-22 | Epimmune Inc | Induktion zellulärer immunantworten gegen humanes immundefiziens virus-1 (hiv-1) mittels peptid- und nukleinsäureverbindungen |
| EP1305333A4 (de) | 2000-07-31 | 2006-04-12 | Active Motif | Peptid-vermittelte lieferung von molekülen in zellen |
-
2000
- 2000-08-25 US US09/648,557 patent/US7790171B1/en not_active Expired - Fee Related
-
2001
- 2001-08-21 DE DE60137340T patent/DE60137340D1/de not_active Expired - Lifetime
- 2001-08-21 AU AU2001292153A patent/AU2001292153A1/en not_active Abandoned
- 2001-08-21 WO PCT/IB2001/001825 patent/WO2002015661A2/en not_active Ceased
- 2001-08-21 EP EP01972382A patent/EP1311538B1/de not_active Expired - Lifetime
- 2001-08-21 AT AT01972382T patent/ATE420103T1/de not_active IP Right Cessation
-
2010
- 2010-08-16 US US12/857,043 patent/US20110064793A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002015661A3 (en) | 2003-01-23 |
| WO2002015661A8 (en) | 2002-11-14 |
| WO2002015661A2 (en) | 2002-02-28 |
| AU2001292153A1 (en) | 2002-03-04 |
| US20110064793A1 (en) | 2011-03-17 |
| DE60137340D1 (de) | 2009-02-26 |
| EP1311538A2 (de) | 2003-05-21 |
| EP1311538B1 (de) | 2009-01-07 |
| US7790171B1 (en) | 2010-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301842A2 (hu) | Laktám vegyület, a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása gyógyszerkészítmény elżállítására | |
| HUP0000492A1 (hu) | N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával | |
| SE0002202D0 (sv) | New peptides | |
| NO974147D0 (no) | Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease | |
| DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| CY1109631T1 (el) | Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ | |
| ATE420103T1 (de) | Inhibitoren von hiv-replikation und verfahren zur behandlung einer der von hiv verursachten infektionen | |
| WO2005002500A3 (en) | Inhibitors of coronavirus | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| DE60131085D1 (de) | Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika | |
| ATE201693T1 (de) | Hämoregulierende peptide | |
| HUP0301523A2 (hu) | VEGF-peptidek és alkalmazásuk angiogenezis gátlására | |
| UY26911A1 (es) | Ácidos amino (oxo) acéticos inhibidores de la proteina tirosina fosfatasa | |
| EP1401490A4 (de) | Tsg101 als inhibitor der hiv-produktion | |
| ATE312179T1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
| ATE285244T1 (de) | Tripeptide und deren derivate zur behandlung von postläsionalen krankheiten des nervensystems | |
| ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
| ATE297720T1 (de) | Campher wässrige lösung zur behandlung degenerativer und autoimmuner erkrankungen sowie als immunomodulator | |
| DE50210473D1 (de) | Phosphinat-peptidanaloga als inhibitoren der procollagen-c-proteinase (pcp) zur behandlung von fibrotischen erkrankungen | |
| DE60034580D1 (de) | Peptid zur behandlung von nervenerkrankungen | |
| ATE310529T1 (de) | Tripeptidderivate zur behandlung von postläsionalen krankheiten des nervensystems | |
| DE60118363D1 (de) | Methoden zur behandlung des kryptorchysmus | |
| ATE386524T1 (de) | Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion | |
| ES541194A0 (es) | Un procedimiento de preparacion de inhibidores de la renina que contienen estatina o sus derivados. | |
| UY25369A1 (es) | Procedimiento para preparar inhibidores de proteasa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |